Myomo, Inc. financial data

Symbol
MYO on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
137 Portland Street, 4 Th Floor, Boston, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 260 % -9.23%
Quick Ratio 35.6 % -1.74%
Debt-to-equity 58.5 % +14.2%
Return On Equity -93.1 % +12.3%
Return On Assets -58.7 % +16.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.2M shares +43.2%
Common Stock, Shares, Outstanding 30.2M shares +43.2%
Entity Public Float 9.53M USD -4.83%
Common Stock, Value, Issued 3.02K USD +43.2%
Weighted Average Number of Shares Outstanding, Basic 37.4M shares +33.5%
Weighted Average Number of Shares Outstanding, Diluted 37.4M shares +33.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 21.1M USD +21.2%
Cost of Revenue 6.89M USD +24.2%
Research and Development Expense 3.56M USD +59.5%
Selling and Marketing Expense 2.78M USD +22.2%
General and Administrative Expense 2.66M USD +4.25%
Operating Income (Loss) -9.46M USD -7.37%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.13M USD -6%
Income Tax Expense (Benefit) 313K USD +704%
Net Income (Loss) Attributable to Parent -9.45M USD -9.14%
Earnings Per Share, Basic -0.26 USD/shares +69%
Earnings Per Share, Diluted -0.26 USD/shares +69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.85M USD -2.67%
Cash, Cash Equivalents, and Short-term Investments 11.1M USD
Accounts Receivable, after Allowance for Credit Loss, Current 2.53M USD +53.9%
Inventory, Net 2.6M USD +94.5%
Assets, Current 15.1M USD +19.9%
Property, Plant and Equipment, Net 289K USD +88.2%
Operating Lease, Right-of-Use Asset 539K USD +80.4%
Other Assets, Noncurrent 220K USD +98%
Assets 16.2M USD +21.8%
Liabilities, Current 6.47M USD +49.1%
Operating Lease, Liability, Noncurrent 47.3K USD -66.1%
Liabilities 6.51M USD +45.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 139K USD +253%
Retained Earnings (Accumulated Deficit) -102M USD -10.2%
Stockholders' Equity Attributable to Parent 9.68M USD +9.72%
Liabilities and Equity 16.2M USD +21.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.25M USD -78.7%
Net Cash Provided by (Used in) Financing Activities 5.36M USD -7.11%
Net Cash Provided by (Used in) Investing Activities -3.54M USD -7758%
Common Stock, Shares Authorized 65M shares 0%
Common Stock, Shares, Issued 30.2M shares +43.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.44M USD -137%
Deferred Tax Assets, Valuation Allowance 14.4M USD -29.6%
Deferred Tax Assets, Gross 14.4M USD -29.6%
Operating Lease, Liability 364K USD +13.2%
Depreciation 29.7K USD -39%
Payments to Acquire Property, Plant, and Equipment 59.8K USD +32.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.35M USD -8.6%
Lessee, Operating Lease, Liability, to be Paid 392K USD +4.87%
Property, Plant and Equipment, Gross 965K USD +16.6%
Operating Lease, Liability, Current 317K USD +74.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 103K USD -35.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.23 pure +15%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28.1K USD -46.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 11.7M USD -34.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 893K USD -13.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%